Ascendis Pharma Shares Nasdaq

On average they expect Ascendis Pharma ASs share price to reach 19200 in the next twelve months. Ascendis Pharma AS shares last traded at 15420 with a volume of 31659 shares changing hands.

8uhic8nsrwjwrm

The stocks price range for the 52-week period managed to maintain the performance between 10936 and 18398.

Ascendis pharma shares nasdaq. See Why Ascendis Pharma Stock Is Shining On Thursday. Q2 GAAP EPS of -250 beats by 014Revenue of 102B -292 YYShares 1794Press Release. How has Ascendis Pharmas share price performed over time and what events caused price changes.

ASND long-acting growth hormone lonapegsomatropin-tcgd. Ascendis Pharma AS NASDAQ. The ASND shares 52-week high r.

At the last check today the stocks price was 15405 to imply an increase of 2457 or 3038 in intraday trading. The companys stock price has collected 343 of gains in the last five trading sessions. Shares of Ascendis Pharma AS are trading about 25 higher on Nasdaq Thursday following news the US.

Lone Pine Capital LLC owned 267 of Ascendis Pharma AS worth 185198000 at the. Ascendis Pharma AS NASDAQASND announced its earnings results on Tuesday. Its 646 higher than it was five years ago.

26082021 444pm Dow Jones News. As of March 31 2021 Ascendis Pharma had 53829379 ordinary shares outstanding. Shares of Ascendis Pharma NASDAQ.

ASND is not significantly more volatile than the rest of US stocks over the past 3 months typically moving - 4 a week. The fund owned 1436981 shares of the biotechnology companys stock after buying an additional 542448 shares during the period. Then look at the Ascendis Pharma AS NASDAQASND share price.

Ascendis Pharma AS NASDAQASNDs traded shares stood at 118 million during the latest session with the companys beta value hitting 076. Ascendis Pharma AS NASDAQASND Intraday Stock. Shares of Ascendis Pharma AS NASDAQASND gapped up prior to trading on Thursday following a better than expected earnings announcement.

Lone Pine Capital LLC boosted its stake in shares of Ascendis Pharma AS NASDAQASND by 606 during the first quarter according to its most recent Form 13F filing with the SEC. Investors are more than a little excited about potential sales of the companys new. Latest Share Price and Events Stable Share Price.

Ascendis Pharma ASND. The biotechnology company reported 250 earnings per share for the quarter beating the consensus estimate of 275 by 025 MarketWatch Earnings reports. Conference Call and Webcast Information DateThursday May 27 2021Time430 pm.

Press Release reported 18 hours ago that Ascendis Pharma AS Reports Second Qua. 10 brokerages have issued 1-year target prices for Ascendis Pharma ASs stock. Ascendis Pharma AS NASDAQASND went up by 2661 from its latest closing price compared to the recent 1-year high of 18398.

Food and Drug Administration approved its Skytrofa as a treatment for Pediatric Growth Hormone Deficiency. Ascendis Pharma Shares Up About 25 After FDA Approval of Skytrofa. Each unit comprises one share of common stock and a warrant to purchase one share of common stock at an exercise price of 1080 per share.

Their forecasts range from 17800 to 21600. The stock had previously closed at 12367 but opened at 15151. Ascendis Pharma AS had a negative net margin of 770088 and a negative return on equity of 5480.

Presently Ascendis Pharma AS shares are logging -1630 during the 52-week period from high price and 4081 higher than the lowest price point for the same timeframe. And this is just one example of. The FDA on Wednesday gave a thumbs-up to Ascendis Pharma ASs NASDAQ.

ASND are on the move following the approval of the companys first drug.

4rmnv1fsny0mzm

Rsi Alert Ascendis Pharma Asnd Now Oversold Nasdaq

Ascendis Pharma A S Nav Akt Spons Adrs 1 Aktie A14m6x Us04351p1012 Kurs Finanzen100

Asnd Institutional Ownership Ascendis Pharma A S

Ascendis Pharma Asnd Investor Presentation Slideshow Nasdaq Asnd Seeking Alpha

Investors In Ascendis Pharma Nasdaq Asnd Have Made A Enviable Return Of 607 Over The Past Five Years

Gscphn0nk4vfdm

Ascendis Pharma A S Nav Akt Spons Adrs 1 Aktie A14m6x Us04351p1012 Kurs Finanzen100

Technical Analysis Of Ascendis Pharma A S Nasdaq Asnd Tradingview

Ascendis Pharma Transcon Platform Is A Major Value Driver Nasdaq Asnd Seeking Alpha

Ascendis Pharma A S Announces Pricing Of Initial Public Offering

Ascendis Pharma A S Nav Akt Spons Adrs 1 Aktie A14m6x Us04351p1012 Kurs Finanzen100

Ascendis Pharma A S Nasdaq Asnd Raised To Hold At Zacks Investment Research Opera News

Ascendis Pharma A S 2018 Annual Transition Report 20 F

E6gdbpcqz39yqm

Pin On Daily Stock Market News

The Prognosis For Ascendis Pharma Nasdaq Asnd Seeking Alpha

Https Investors Ascendispharma Com Financial And Filings Annual General Meetings 2020 Annual Report

Twhry0utzt5jmm